1. Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation
   Robert L. Ferris et al, 2017, Cancer Treatment Reviews CrossRef
2. Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients
   A. Mitsuhashi et al, 2018, Clin Transl Oncol CrossRef
3. Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
   Rebekka Weber et al, 2018, Front. Immunol. CrossRef
4. Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.
   Qianquan Ma et al, 2018, Front Immunol CrossRef
5. Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance
   Yaqi Li et al, 2019, Immunology Letters CrossRef
6. A general platform for efficient extracellular expression and purification of Fab from Escherichia coli
   Manyu Luo et al, 2019, Appl Microbiol Biotechnol CrossRef
7. Antitumor activity of the PD-1/PD-L1 binding inhibitor BMS-202 in the humanized MHC-double knockout NOG mouse
   Tadashi ASHIZAWA et al, 2019, Biomed. Res. CrossRef
8. Anti-Inflammatory Action of Heterogeneous Nuclear Ribonucleoprotein A2/B1 in Patients with Autoimmune Endocrine Disorders
   Antonina Coppola et al, 2019, JCM CrossRef
9. Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors.
   Aohan Hou et al, 2020, Front Immunol CrossRef
10. Cutaneous melanoma: From pathogenesis to therapy (Review).
    Giulia C Leonardi et al, 2018, Int J Oncol CrossRef
11. Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies
    Alejandro Olivares-Hernández et al, 2021, JCM CrossRef
12. Immune normalization strategy against suboptimal health status: safe and efficacious therapy using mixed-natural killer cells
    Ying Li et al, 2021, Aging CrossRef
13. Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model
    Said Ahmed Bahwal et al, 2022, J Cancer Res Clin Oncol CrossRef
14. Cell Membrane Surface-Engineered Nanoparticles for Dermal Wound Healing and Melanoma (Regenerative Medicine and Cancer Therapy of Skin)
    Zainab Ahmadian et al, 2024 CrossRef
15. Combining Anti-epidermal Growth Factor Receptor (EGFR) Therapy with Immunotherapy in Metastatic Colorectal Cancer (mCRC)
    Feng Xiong et al, 2024, Expert Review of Gastroenterology & Hepatology CrossRef
16. Nanoparticle-Delivered HIV Peptides to Dendritic Cells a Promising Approach to Generate a Therapeutic Vaccine.
    Alba Martín-Moreno et al, 2020, Pharmaceutics CrossRef
17. A Rare Presentation of Malignant Melanoma of the Face: A Case Report
    Apurva Palatkar et al, 2024 CrossRef